PATTERN OF ALLOIMMUNE RESPONSE IN SECOND SAME DONOR ALLOGRAFTS AFTER INDUCTION OF TOLERANCE USING CTLA4Ig1
- 1 December 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 72 (12) , 1952-1956
- https://doi.org/10.1097/00007890-200112270-00015
Abstract
The pattern of allograft acceptance in the presence of costimulatory blockade is manifested by the sequential appearance of Th1 cells, followed by Th2 cells. The aim of this study was to examine whether this phenomenon repeats itself after second same donor allotransplantation, hoping to determine whether acceptance in this setting provokes a predominance of the Th2 response. Tolerance was achieved by transplantation of CTLA4Ig-transduced ACI liver allografts in Lewis recipients. Recipient long-term survivors received a second transplant, consisting of a cervical heterotopic heart from the same ACI donor strain. Animals were sacrificed at predetermined intervals following the second transplant and the heart and liver were processed for histology and cytokine mRNA expression. Recipients of CTLA4Ig-transduced livers survived indefinitely. Rechallenge with same donor strain second allograft was manifested by an anergic immune response in the second cardiac allograft, and a very mild transient infiltrate within the first accepted liver graft. Cardiac function was maintained with resolution of all infiltrates. The cytokine cascade was activated within the allografts; however, the pattern of acceptance was not associated with predominance of a specific Th subtype. The pattern of acceptance of an allograft following CTLA4Ig-mediated costimulatory blockade is not related to long-term predominance of Th2 cells, a phenomenon that may be unique to the setting of a tolerant liver. It may be likely that the infiltrating lymphocytes that are dominant in the second graft are suppressed by other memory mechanisms.Keywords
This publication has 20 references indexed in Scilit:
- The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivoJournal of Clinical Investigation, 2000
- Tolerance to Cardiac Allografts Via Local and Systemic Mechanisms After Adenovirus-Mediated CTLA4Ig ExpressionThe Journal of Immunology, 2000
- CARDIAC ALLOGRAFT TOLERANCE INDUCED BY INTRAARTERIAL INFUSION OF RECOMBINANT ADENOVIRAL CTLA4Ig1Transplantation, 1999
- Anti-Adenovirus Immune Responses in Rats Are Enhanced by Interleukin 4 but Not Interleukin 10 Produced by Recombinant AdenovirusHuman Gene Therapy, 1998
- Adenovirus-mediated gene transfer into cold-preserved liver allografts: Survival pattern and unresponsiveness following transduction with CTLA4IgNature Medicine, 1998
- ARE Th2 HELPER T LYMPHOCYTES BENEFICIAL, DELETERIOUS, OR IRRELEVANT IN PROMOTING ALLOGRAFT SURVIVAL?1Transplantation, 1997
- MANIPULATION OF CYTOKINE NETWORKS IN TRANSPLANTATIONTransplantation, 1997
- Viral IL-10 gene therapy inhibits TNF-α and IL-1β, not IL-6, in the newborn endotoxemic mouseJournal of Pediatric Surgery, 1996
- CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.The Journal of Experimental Medicine, 1995
- Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion.The Journal of Experimental Medicine, 1993